Biologics Commonly Used in Cutaneous Crohn's Disease - Takeaways - MDSpire

Biologics Commonly Used in Cutaneous Crohn's Disease

Retrospective multicenter cohort highlights genital-predominant presentation patterns and frequent combination therapy use in cutaneous Crohn's disease.

  • By

  • Andrea Surnit

  • May 27, 2026

  • 3 min

Share

  • 1

    A retrospective study found that most patients with cutaneous Crohn disease improved after receiving biologic or small-molecule inhibitor therapy.

  • 2

    The study reviewed data from 57 patients, with 81% being female and a mean diagnosis age of 37 years.

  • 3

    Genital involvement was the most common cutaneous presentation, occurring in 44% of patients.

  • 4

    Tumor necrosis factor alpha inhibitors were the most frequently prescribed biologics, used in 85% of treated patients.

  • 5

    The study's limitations include its uncontrolled design and variability in treatment regimens across institutions.

Original Source(s)

Biologics Commonly Used in Cutaneous Crohn's Disease

  • by Andrea Surnit

  • May 27, 2026

Related Content

Low-Dose Oral Minoxidil Monitoring Questioned

A retrospective hair clinic study found stable blood pressure, heart rate, weight, and laboratory measures during follow-up of up to 30 months.

IL-17, IL-23 Therapies Lead Psoriasis Care

Network meta-analysis suggests higher PASI 90 response rates with biologics vs oral systemic therapies

Facial Hemangiomas May Signal PHACE

Early recognition of segmental facial lesions prompted diagnosis and multidisciplinary care in an infant with multisystem involvement